[The interpretation of 2020 American College of Rheumatology guideline for the management of gout].

Cao, L; Zhu, X X; Xue, Y; Lin, C; Wan, W G; Zou, H J

Cao, L; Zhu, X X; Xue, Y; Lin, C; Wan, W G; Zou, H J.

Afiliación

Cao L; Department of Rheumatology and Immunology,Huashan Hospital, Insitute of Rheumatology,Immunology and Allergy,Fudan University,Shanghai 200040,China.
Zhu XX; Department of Rheumatology and Immunology,Huashan Hospital, Insitute of Rheumatology,Immunology and Allergy,Fudan University,Shanghai 200040,China.
Xue Y; Department of Rheumatology and Immunology,Huashan Hospital, Insitute of Rheumatology,Immunology and Allergy,Fudan University,Shanghai 200040,China.
Lin C; Department of Rheumatology and Immunology,Huashan Hospital, Insitute of Rheumatology,Immunology and Allergy,Fudan University,Shanghai 200040,China.
Wan WG; Department of Rheumatology and Immunology,Huashan Hospital, Insitute of Rheumatology,Immunology and Allergy,Fudan University,Shanghai 200040,China.
Zou HJ; Department of Rheumatology and Immunology,Huashan Hospital, Insitute of Rheumatology,Immunology and Allergy,Fudan University,Shanghai 200040,China.

Zhonghua Nei Ke Za Zhi ; 59(8): 645-648, 2020 Aug 01.

Article en Zh | MEDLINE | ID: mdl-34865385

Asunto(s)

Gota; Reumatología; Gota/tratamiento farmacológico; Supresores de la Gota/uso terapéutico; Humanos; Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reumatología / Gota Tipo de estudio: Guideline Límite: Humans País/Región como asunto: America do norte Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google